Cargando…

Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients

BACKGROUND AND AIMS: Stereotactic body radiotherapy (SBRT) is a relatively new treatment for liver tumor. The outcomes of SBRT for liver tumor unfit for ablation and surgical resection were evaluated. METHODS: Liver tumor patients treated with SBRT in seven Japanese institutions were studied retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Hideomi, Onishi, Hiroshi, Matsumoto, Yasuo, Murakami, Naoya, Matsuo, Yukinori, Nomiya, Takuma, Nakagawa, Keiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029909/ https://www.ncbi.nlm.nih.gov/pubmed/24886477 http://dx.doi.org/10.1186/1748-717X-9-112

Ejemplares similares

Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database
por: Shioyama, Yoshiyuki, et al.
Publicado: (2018)

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for Small Lung Tumors in the University of Tokyo Hospital
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
por: Takahashi, Wataru, et al.
Publicado: (2012)

Comparative Analysis of Photon Stereotactic Radiotherapy and Carbon-Ion Radiotherapy for Elderly Patients with Stage I Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study
por: Aoki, Shuri, et al.
Publicado: (2023)

Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review
por: Aoki, Shuri, et al.
Publicado: (2020)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for Patients with Pulmonary Interstitial Change: High Incidence of Fatal Radiation Pneumonitis in a Retrospective Multi-Institutional Study
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Factors related to primary cancer death and non‐primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2022)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms
por: Takahashi, Wataru, et al.
Publicado: (2012)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview
por: Matsuo, Yukinori
Publicado: (2023)

Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
por: Ogita, Mami, et al.
Publicado: (2021)

Linear accelerator-based stereotactic body radiation therapy in the treatment of oligometastatic disease
por: Yamashita, Hideomi, et al.
Publicado: (2020)

Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study
por: Aoki, Shuri, et al.
Publicado: (2018)

Novel breath-hold liver target stereotactic ablative radiotherapy using the intrafraction diaphragm registration of kilovoltage projection streaming image with digitally reconstructed radiography of the planning computed tomography
por: Katano, Atsuto, et al.
Publicado: (2023)

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
por: Yamamoto, Takaya, et al.
Publicado: (2020)

A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer
por: Matsuo, Yukinori
Publicado: (2018)

Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2021)

Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Lung tumor motion reproducibility for five patients who received four-fraction VMAT stereotactic ablative body radiotherapy under constrained breathing conditions: a preliminary study
por: Nakagawa, Keiichi, et al.
Publicado: (2014)

Palliative radiotherapy for gross hematuria in patients with advanced cancer
por: Ogita, Mami, et al.
Publicado: (2021)

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy
por: Yamashita, Hideomi, et al.
Publicado: (2010)

Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy as an Alternative to Definitive Surgery in Cancers of Various Organs
por: Shibamoto, Yuta, et al.
Publicado: (2018)

Development of Japanese Cancer Intelligence Quotient to Measure Cancer Literacy and Knowledge among Japanese Laypersons
por: Minamitani, Masanari, et al.
Publicado: (2022)

Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia
por: YAMASHITA, MAMI, et al.
Publicado: (2015)

Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report
por: Nonaka, Hotaka, et al.
Publicado: (2017)

The Spontaneous Remission of Recurrent Lymph Node Metastatic Prostate Cancer With Lowering Serum Prostate-Specific Antigen Level
por: Katano, Atsuto, et al.
Publicado: (2022)

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016)

National Survey of Radiotherapy Utilization Trends from 2015 to 2019, Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Katano, Atsuto, et al.
Publicado: (2023)

Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
por: Yamashita, Hideomi, et al.
Publicado: (2007)

Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients
por: Aoki, Shuri, et al.
Publicado: (2020)

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study
por: Eriguchi, Takahisa, et al.
Publicado: (2013)

Prognostic factors in patients after definitive chemoradiation using involved‐field radiotherapy for esophageal cancer in a phase II study
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Quality of life after definitive linear accelerator-based stereotactic radiotherapy for prostate cancer: a longitudinal study
por: Yamashita, Hideomi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rac5057oeq1cicgic26kha0b4h